{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:21:55Z","timestamp":1792009315257,"version":"4.4.0"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,1]]},"DOI":"10.1097\/qai.0b013e318256f3bc","type":"journal-article","created":{"date-parts":[[2012,5,8]],"date-time":"2012-05-08T07:36:59Z","timestamp":1336462619000},"page":"234-243","source":"Crossref","is-referenced-by-count":172,"title":["Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection"],"prefix":"10.1097","volume":"60","author":[{"given":"Anupa","family":"Kamat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Uno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Morgello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse J.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Gabuzda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210131","first-page":"1367","article-title":"HIV-associated neurocognitive disorders: is there a hidden epidemic AIDS.","volume":"24","author":"McArthur","year":"2010","journal-title":""},{"key":"R2-4-20210131","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22053","article-title":". Human immunodeficiency virus-associated neurocognitive disorders: mind the gap.","volume":"67","author":"McArthur","year":"2010","journal-title":"Ann Neurol"},{"key":"R3-4-20210131","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/13550280290049615","article-title":". HIV-associated cognitive impairment before and after the advent of combination therapy.","volume":"8","author":"Sacktor","year":"2002","journal-title":"J Neurovirol"},{"key":"R4-4-20210131","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13550280590952790","article-title":". Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort.","volume":"11","author":"Tozzi","year":"2005","journal-title":"J Neurovirol"},{"key":"R5-4-20210131","doi-asserted-by":"crossref","first-page":"e2516","DOI":"10.1371\/journal.pone.0002516","article-title":". Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.","volume":"3","author":"Ancuta","year":"2008","journal-title":"PLoS One"},{"key":"R6-4-20210131","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1086\/323036","article-title":". Plasma levels of soluble CD14 and tumor necrosis factor-alpha type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infection.","volume":"184","author":"Ryan","year":"2001","journal-title":"J Infect Dis"},{"key":"R7-4-20210131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/13550280290049525","article-title":"Insights into the role of immune activation in HIV neuropathogenesis.","volume":"8","author":"Gartner","year":"2002","journal-title":"J Neurovirol"},{"key":"R8-4-20210131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The neuropathogenesis of AIDS.","volume":"5","author":"Gonzalez-Scarano","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"R9-4-20210131","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-4690-7-30","article-title":"Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection.","volume":"7","author":"Gras","year":"2010","journal-title":"Retrovirology"},{"issue":"suppl 1","key":"R10-4-20210131","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/sj.cdd.4401623","article-title":". HIV-1 infection and AIDS: consequences for the central nervous system.","volume":"12","author":"Kaul","year":"2005","journal-title":"Cell Death Differ"},{"key":"R11-4-20210131","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.410420503","article-title":". Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.","volume":"42","author":"Ellis","year":"1997","journal-title":"Ann Neurol"},{"key":"R12-4-20210131","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0165-5728(99)00219-2","article-title":". Cerebrospinal fluid beta2-microglobulin, monocyte chemotactic protein-1, and soluble tumour necrosis factor alpha receptors before and after treatment with lamivudine plus zidovudine or stavudine.","volume":"102","author":"Enting","year":"2000","journal-title":"J Neuroimmunol"},{"key":"R13-4-20210131","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410420504","article-title":". Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.","volume":"42","author":"McArthur","year":"1997","journal-title":"Ann Neurol"},{"key":"R14-4-20210131","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/514001","article-title":". Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage.","volume":"175","author":"Brew","year":"1997","journal-title":"J Infect Dis"},{"key":"R15-4-20210131","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/00002030-199811000-00014","article-title":". Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication.","volume":"12","author":"Cinque","year":"1998","journal-title":"AIDS"},{"key":"R16-4-20210131","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1073\/pnas.95.6.3117","article-title":". Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia.","volume":"95","author":"Conant","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-4-20210131","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ana.410440521","article-title":". Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia.","volume":"44","author":"Kelder","year":"1998","journal-title":"Ann Neurol"},{"key":"R18-4-20210131","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/00002030-199809000-00009","article-title":". Chemokines and receptors in HIV encephalitis.","volume":"12","author":"Sanders","year":"1998","journal-title":"AIDS"},{"key":"R19-4-20210131","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1212\/01.WNL.0000145763.68284.15","article-title":". Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.","volume":"63","author":"Sevigny","year":"2004","journal-title":"Neurology"},{"key":"R20-4-20210131","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ana.410280413","article-title":". Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.","volume":"28","author":"Brew","year":"1990","journal-title":"Ann Neurol"},{"key":"R21-4-20210131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.41.1.69","article-title":"Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease.","volume":"41","author":"Griffin","year":"1991","journal-title":"Neurology"},{"key":"R22-4-20210131","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1471-4159.1992.tb08471.x","article-title":". Increased neopterin levels in brains of patients with human immunodeficiency virus type 1 infection.","volume":"59","author":"Shaskan","year":"1992","journal-title":"J Neurochem"},{"key":"R23-4-20210131","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/00002030-199211000-00010","article-title":". Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis.","volume":"6","author":"Wiley","year":"1992","journal-title":"AIDS"},{"key":"R24-4-20210131","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1172\/JCI116518","article-title":"Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains.","volume":"91","author":"Achim","year":"1993","journal-title":"J Clin Invest"},{"key":"R25-4-20210131","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/jnnp.55.3.219","article-title":". Tumour necrosis factor (TNF-alpha) and neurological disorders in HIV infection.","volume":"55","author":"Mastroianni","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R26-4-20210131","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.21225","article-title":". Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.","volume":"63","author":"Bhaskaran","year":"2008","journal-title":"Ann Neurol"},{"key":"R27-4-20210131","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1086\/523648","article-title":". Immune activation of the central nervous system is still present after 4 years of effective highly active antiretroviral therapy.","volume":"196","author":"Eden","year":"2007","journal-title":"J Infect Dis"},{"key":"R28-4-20210131","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.qai.0000165799.59322.f5","article-title":". Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients.","volume":"39","author":"Cysique","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-4-20210131","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-6405-7-15","article-title":". Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.","volume":"7","author":"Hagberg","year":"2010","journal-title":"AIDS Res Ther"},{"key":"R30-4-20210131","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/QAI.0b013e31815ace97","article-title":". Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy.","volume":"47","author":"Yilmaz","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R31-4-20210131","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/QAI.0b013e3182237e54","article-title":". Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.","volume":"57","author":"Lyons","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R32-4-20210131","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1080\/135502801753248114","article-title":". CNS invasion by CD14CD16 peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection.","volume":"7","author":"Fischer-Smith","year":"2001","journal-title":"J Neurovirol"},{"key":"R33-4-20210131","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/135965350400900302","article-title":". Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.","volume":"9","author":"Chang","year":"2004","journal-title":"Antivir Ther"},{"key":"R34-4-20210131","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13365-010-0013-2","article-title":". Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals.","volume":"17","author":"Letendre","year":"2011","journal-title":"J Neurovirol"},{"key":"R35-4-20210131","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":". Updated research nosology for HIV-associated neurocognitive disorders.","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"R36-4-20210131","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/13803390490509565","article-title":". Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV.","volume":"26","author":"Woods","year":"2004","journal-title":"J Clin Exp Neuropsychol"},{"key":"R37-4-20210131","doi-asserted-by":"crossref","first-page":"RESEARCH0032","DOI":"10.1186\/gb-2001-2-8-research0032","article-title":"Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application.","volume":"2","author":"Li","year":"2001","journal-title":"Genome Biol"},{"key":"R38-4-20210131","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1073\/pnas.98.1.31","article-title":"Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection.","volume":"98","author":"Li","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R39-4-20210131","doi-asserted-by":"crossref","first-page":"e9166","DOI":"10.1371\/journal.pone.0009166","article-title":". Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.","volume":"5","author":"Domenici","year":"2010","journal-title":"PLoS One"},{"key":"R40-4-20210131","doi-asserted-by":"crossref","first-page":"W652","DOI":"10.1093\/nar\/gkp356","article-title":". MetaboAnalyst: a web server for metabolomic data analysis and interpretation.","volume":"37","author":"Xia","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"R41-4-20210131","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1021\/ac051495j","article-title":". Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation.","volume":"78","author":"Bijlsma","year":"2006","journal-title":"Anal Chem"},{"key":"R42-4-20210131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11481-005-9001-3","article-title":". Neuroimmunity, drugs of abuse, and neuroAIDS.","volume":"1","author":"Burdo","year":"2006","journal-title":"J Neuroimmune Pharmacol"},{"key":"R43-4-20210131","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11065-009-9101-6","article-title":"Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features.","volume":"19","author":"Martin-Thormeyer","year":"2009","journal-title":"Neuropsychol Rev"},{"key":"R44-4-20210131","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/135502801300069737","article-title":". Acceleration of HIV dementia with methamphetamine and cocaine.","volume":"7","author":"Nath","year":"2001","journal-title":"J Neurovirol"},{"key":"R45-4-20210131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":". Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system.","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch Neurol"},{"key":"R46-4-20210131","first-page":"45","article-title":". Neurologic complications of HIV disease and their treatment.","volume":"18","author":"Letendre","year":"2010","journal-title":"Top HIV Med"},{"key":"R47-4-20210131","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00126334-200012150-00007","article-title":". Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.","volume":"25","author":"Gisolf","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R48-4-20210131","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jneuroim.2005.07.002","article-title":". Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.","volume":"168","author":"Cinque","year":"2005","journal-title":"J Neuroimmunol"},{"key":"R49-4-20210131","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09540260701878082","article-title":"Biomarkers of HIV related central nervous system disease.","volume":"20","author":"Brew","year":"2008","journal-title":"Int Rev Psychiatry"},{"key":"R50-4-20210131","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/QAI.0b013e318162754f","article-title":". Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection.","volume":"47","author":"Sinclair","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R51-4-20210131","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1073\/pnas.93.2.700","article-title":". Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes.","volume":"93","author":"Schmidtmayerova","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R52-4-20210131","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1086\/314866","article-title":"Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1.","volume":"180","author":"Letendre","year":"1999","journal-title":"J Infect Dis"},{"key":"R53-4-20210131","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/QAD.0b013e3283427da7","article-title":". Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment.","volume":"25","author":"Harezlak","year":"2011","journal-title":"AIDS"},{"key":"R54-4-20210131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jmv.21879","article-title":". Hepatitis C infection, cognition, and inflammation in an Egyptian sample.","volume":"83","author":"Farag","year":"2011","journal-title":"J Med Virol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-201207010-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T05:51:25Z","timestamp":1713937885000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201207010-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,1]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e318256f3bc","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,1]]}}}